Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. M. Tainton
The Histone Deacetylase Inhibitor and Chemotherapeutic Agent Suberoylanilide Hydroxamic Acid (SAHA) Induces a Cell-Death Pathway Characterized by Cleavage of Bid and Production of Reactive Oxygen Species
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Suberoylanilide Hydroxamic Acid (SAHA)-Induced Dynamics of a Human Histone Deacetylase Protein Interaction Network
Molecular and Cellular Proteomics
Biochemistry
Medicine
Analytical Chemistry
Molecular Biology
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Alleviates Salinity Stress in Cassava
Frontiers in Plant Science
Plant Science
Synergistic Effects of Combined Treatment With Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and TRAIL on Human Breast Cancer Cells
Scientific Reports
Multidisciplinary
The Proteasome Inhibitor Bortezomib Interacts Synergistically With the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid to Induce T-Leukemia/Lymphoma Cells Apoptosis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer in Vitro and in Vivo
PLoS ONE
Multidisciplinary
The Role of Oxidative Stress in Apoptosis Induced by the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid in Human Colon Adenocarcinoma HT-29 Cells
International Journal of Oncology
Cancer Research
Oncology
Histone Deacetylase Inhibitor SAHA Suppresses Human Adenovirus Gene Expression and Replication
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Suberoylanilide Hydroxamic Acid (SAHA) Changes microRNA Expression Profiles in A549 Human Non-Small Cell Lung Cancer Cells
International Journal of Molecular Medicine
Medicine
Genetics
Suberoylanilide Hydroxamic Acid (SAHA) Enhances Olaparib Activity by Targeting Homologous Recombination DNA Repair in Ovarian Cancer
Gynecologic Oncology
Gynecology
Oncology
Obstetrics